Kirby's post | Quora

Is Vaxart Stock the Hidden Gem of 2024? 💡 Okay, let’s talk about Vaxart stock (VXRT). If you’re like me and love hunting for the next big thing in biotech, you’ve probably come across this ticker at least a dozen times, right? And if you haven’t, well, sit tight—because this is one wild ride you’ll want to buckle up for. My First Encounter with Vaxart 🧐 I first stumbled upon Vaxart back in the chaos of 2020. Everyone was talking about vaccine stocks, and VXRT was suddenly everywhere on my feed. What caught my attention? Unlike the giants (you know who I mean), Vaxart was all about oral vaccines. Imagine popping a pill instead of getting a shot. For someone who’s always dreaded needles, this sounded like a dream! Why Vaxart Stands Out What I find super interesting about Vaxart is their commitment to changing the way we think about vaccines. No more waiting in long lines at clinics or bracing for that sting in your arm. Their tech aims to make it as easy as taking your daily vitamins. If that’s not disruptive, I don’t know what is. But let’s be real—this stock isn’t for the faint of heart. The price swings? Oh man, they’re wild. I remember last year watching VXRT go from “meh” to “wow” in a matter of days, and then back again. It’s like being on a rollercoaster at a biotech amusement park. Some folks thrive on that adrenaline, but others might want to look away! The Risks and Rewards (Yes, Both!) Here’s where I get honest: Vaxart is still a small player, and their products are largely in the trial phase. There are risks, from FDA hurdles to competition with well-funded giants. I’ve seen some people jump in hoping for a moonshot, only to bail when the ride gets bumpy. I get it—no one wants to lose money. But honestly, innovation doesn’t come with guarantees. Sometimes you have to be okay with uncertainty if you want to be part of something revolutionary. On the flip side, if Vaxart’s approach works out, it could be HUGE. Think about travel, schools, even how we handle outbreaks in the future. An oral vaccine could be a total game-changer. Every time I dig into their research updates, I get this buzz of excitement. The “what if” is just so compelling. What I’m Doing Personally So, am I all-in on VXRT? Not quite. I’ve got a small position, just enough to keep me invested (literally and emotionally) but not so much that I’m losing sleep. I like to keep my biotech bets diversified because, let’s face it, this sector can be brutal. But having a little VXRT in my portfolio is like holding a lottery ticket for the future of medicine. It keeps things interesting. Final Thoughts: Worth a Closer Look? If you’re thinking about Vaxart stock, my advice is simple: do your homework, watch the news, and be ready for a wild ride. This isn’t your grandma’s blue-chip stock. But for those who love a good underdog story—and don’t mind a little drama—VXRT might just be the ticket. Have you already jumped on the Vaxart train, or are you still watching from the sidelines? I’d love to hear your thoughts, your wins, your “oh no” moments, and everything in between. Let’s swap stories and see where this journey takes us! Bottom line: Vaxart stock might not be everyone’s cup of tea, but for me, it’s a fascinating play on the future of vaccines. Here’s to hoping for breakthroughs—and maybe a little portfolio magic along the way!